Written by the AllMyPeptides Research Team
What Is Thymosin Alpha-1?
Thymosin Alpha-1 (Tα1, also called thymalfasin) is a 28-amino-acid peptide derived from prothymosin alpha and originally isolated from the thymus. It is studied as an immune-modulating peptide.
Research use only. This material is supplied for in-vitro laboratory research. It is not a medicine and is not for human or veterinary consumption, administration, or therapeutic use.
How Thymosin Alpha-1 Is Studied to Work
In research Tα1 is associated with modulation of T-cell function, dendritic-cell activity and other components of immune signalling. It has been studied as an immune adjuvant and in models of infection and immune dysfunction.
Evidence & Regulatory Status
Thymosin Alpha-1 is approved as a medicine (thymalfasin) in a number of countries for specific indications such as certain viral hepatitis and as an immune adjuvant; it does not hold a UK marketing authorisation for general use. Research-grade Tα1 is supplied for laboratory research only.
Research Handling & Quality
As a lyophilised (freeze-dried) peptide it is typically stored frozen and reconstituted with bacteriostatic water for in-vitro work — see our reconstitution guide and storage guide. Identity and purity should be verified against a batch-matched Certificate of Analysis (COA) with HPLC and mass-spectrometry data. View thymosin-alpha-1 product details and COA.
Frequently Asked Questions
Is Thymosin Alpha-1 approved in the UK?+
What is Thymosin Alpha-1 studied for?+
How is Thymosin Alpha-1 stored?+
Related Guides
Products discussed in this guide are for research and laboratory use only. AllMyPeptides does not condone or support misuse of any research materials. Not for human or animal consumption.